• Text size      
  • Send this article to a friend
  • Print this article

Prostrakan deal completed

PROSTRAKAN has formally completed its £230 million deal for European pharmaceutical rival Archimedes Pharma.

It comes after the Scottish company, which employs around 100 of its 300 staff at its headquarters in Galashiels, received the go-ahead to finalise the transaction from anti-trust authorities in Germany.

Archimedes, which is being sold by Danish private equity firm Novo, has its headquarters in Reading, a facility in Nottingham and a sales and marketing presence across Europe.

Contextual targeting label: 

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.